Difference between revisions of "Fibrinogen gamma chain (TG2)"
m |
m |
||
Line 46: | Line 46: | ||
|- | |- | ||
| Notes | | Notes | ||
− | | [[Minor TG2 reactive residues (Fibrinogen gamma)| | + | | [[Minor TG2 reactive residues (Fibrinogen gamma)|Q144, Q195, Q239, Q311]] are minor substrate sites considering modification by TG2 |
|- | |- | ||
| {{infobox header}} | | | {{infobox header}} | |
Revision as of 13:16, 12 June 2008
Template:Infobox header| Fibrinogen gamma chain (TG2) | |
---|---|
Substrate peptide name | Fibrinogen gamma chain |
Synonyms | - |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Extracellular; plasma |
Swissprot ID | P02679 |
Reactive glutamines | Q398 |
Reactive lysines | K406 |
Substrate sequence | TIGEGQQHHLGGAKQVRPE |
Structure | 1FID |
Surface accessibility | ASAView pdf
ASAView txt |
Disorder prediction | IUPred |
Reference | PMID:2902081 |
Notes | Q144, Q195, Q239, Q311 are minor substrate sites considering modification by TG2 |
Template:Infobox header | |